The Effect of Conservative Treatment on Bladder Diary Parameters in Women With Urgency Urinary Incontinence and Mixed Urinary Incontinence
In brief
TätII users recorded two-thirds fewer leakage episodes after 15 weeks
In bladder diaries from 123 women with urgency or mixed urinary incontinence, those using the TätII app reported 0.5 leakage episodes versus 1.5 in the control group after 15 weeks. They also logged less frequent voiding and less severe leakage and urgency, while voided volume did not change; the findings quantify diary changes, not whether benefits last longer.
- Journal
- Neurourology and urodynamics (Q1)
- Published
- 21 October 2026
- Study design
- Randomized controlled trial
- Evidence level
- Level 1, High (CEBM 1b)
- Authors
- Annelie Olofsson, Towe Wadensten, Anna Lindam, Ina Asklund, Emma Nyström
- PMID
- 42904848
- DOI
- 10.1002/nau.70493
Why clinicians should know about it
- Picked for Urology (top studies of the week, 8 November 2026): App-based treatment significantly reduces leakage episodes
Abstract
BACKGROUND: Urinary incontinence (the involuntary loss of urine) is a worldwide problem, and bladder diaries are used to characterize the nature and severity of the disease. eHealth and mobile apps are used as tools to aid in conservative treatment, and the mobile app TätII has been developed for the treatment of urgency urinary incontinence (UUI) and mixed urinary incontinence (MUI) in women. PURPOSE: The aim of this study was to evaluate how conservative treatment affected bladder diary parameters in women with UUI and MUI. METHODS: For this purpose, bladder diaries produced by 123 participants in a previously performed randomized controlled trial (RCT) using TätII were analyzed before and after 15 weeks of treatment. The variables extracted from the bladder diaries included measures of voiding volume, voiding frequency, urinary leakage, and urgency; these were analyzed with non-parametric methods, with between-group comparisons performed using the Mann-Whitney U test. RESULTS: Compared to the control group, the participants in the treatment group reported a significant decrease (p < 0.01) in voiding frequency (6 vs. 7.5), leakage episodes (0.5 vs. 1.5), leakage grade (0.5 vs. 1.29), and urgency intensity (1.17 vs. 1.5) at the 15-week follow-up. Interestingly, the voiding volume did not change. CONCLUSION: The results show that treatment of UUI and MUI with TätII has a significant effect on bladder diary parameters. This is the first study to describe a change in bladder diary parameters after conservative treatment of UUI and MUI and provides objective measurements of treatment effects. CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov-NCT03097549.
Abstract as published, via PubMed.
For healthcare professionals. The summary is generated by AI from the published abstract, and the evidence level is assigned automatically from the study design on the Oxford CEBM hierarchy. Neither is medical advice. Read the full paper before changing practice.